View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Alexander Aukner
  • Alexander Aukner

Benchmark Holdings Plc (Buy, TP: NOK6.30) - Genetics divestment approa...

Benchmark Holdings’ sale of its Genetics business to Novo Holdings announced in November 2024 is guided to close in calendar Q1 2025. The initial consideration of GBP230m (plus GBP30m in potential earnout) is set to be used to pay down debt and excess capital returned to shareholders. We have adjusted our estimates after the Q1 results, as Benchmark Holdings will retain more short-term corporate costs than previously expected. We reiterate our BUY but have cut our target price to NOK6.3 (7.2).

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch